期刊文献+

血浆BNP检测在慢性心力衰竭诊断及预后评估中的意义 被引量:16

Significance of plasma BNP for diagnosis and prognosis in chronic heart failure
下载PDF
导出
摘要 目的探讨血浆BNP检测在慢性心衰诊断及预后评估中的临床意义。方法回顾性分析慢性心力衰竭患者100例的临床资料,分析BNP水平与心功能分级、左室射血分数、左室舒张末期内径的关系。并根据BNP水平分为>400pg/mL组和≤400pg/mL组,比较两组患者房颤、陈旧性心肌梗死以及死亡率。结果随着心功能分级的升高,BNP水平显著升高,LVEF水平显著下降,LVEDD显著增加(P<0.01)。BNP与心功能分级和LVEDD呈正相关(r=0.921,0.917,P<0.01),与LVEF呈负相关(r=-0.960,P<0.01)。BNP水平>400pg/mL的患者房颤、陈旧性心梗的发生率及死亡率更高(P<0.05或<0.01)。结论血浆BNP水平检测能够反映慢性心衰患者左心室功能,对患者诊断、预后评估均具有重要的临床意义。 Objective To discuss Significance of BNP for diagnosis and prognosis in chronic heart failure. Methods Selected 100 cases with chronic heart failure were retrospectively studied. Relationships between BNP and NYHA, LVEF, LVEDD were analyzed. All patients were divided into〉400pg/mL group and ≤ 400pg/mL group according to BNP levels, and AF, old myocardial infarction and mortality rates were compared. Results With the increase of cardiac function, BNP levels were significantly increased, LVEF significantly decreased, and LVEDD significantly increased(P 〈 0.01). BNP showed a significant positive correlation with cardiac function and LVEDD (r=0.921,0.917,P 〈 0.01), and showed a significant negative correlation with LVEF(r= -0.960, P 〈 0.01). AF, old myocardial infarction and mortality rates in 〉 400pg/mL group were higher than ≤ 400pg/mL group(P 〈 0.05 or〈 0.01). Conclusion Detection of plasma BNP levels reflects left ventricular function in patients with chronic heart failure, and has important clinical significance for diagnosis and prognosis.
作者 郭杏花
出处 《中国医药科学》 2014年第21期189-190,201,共3页 China Medicine And Pharmacy
关键词 BNP 性心力衰竭 预后评估 房颤 陈旧性心肌梗死 BNP Chronic heart failure Prognosis AF Qld myocardial infarction
  • 相关文献

参考文献12

二级参考文献78

共引文献100

同被引文献178

  • 1高东奔,邵超华,梁淑兰,裴华,谭艳芬.NT-proBNP对陈旧性心肌梗死患者心力衰竭的诊断价值[J].安徽医学,2013,34(10):1459-1461. 被引量:2
  • 2Cleland JG, Taylor J, Freemantle N. et al. Relationship between plasma concentrations of N - terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP - CHF study [ J 1. Eur J Heart Fail, 2012, 14 (5) : 487 -494.
  • 3Madias JE. Comparison of lead aVR " net QRS area" and " peak - to - peak amplitude" as indices of all limb electrocardiogram leads: Implications for the diagnosis, management, and follow - up in patients with heart failure [J]. Med Eng Phys, 2012, 34 (8): 1037 - 1040.
  • 4McMurray J J, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 : The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [J]. Eur Heart J, 2012, 33 (14) : 1787 -1847.
  • 5Mahadevan G, Dwivedi G, Williams L, et al. Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study [ J ]. Eur J Heart Fail, 2012, 14 (1): 106-112.
  • 6无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3667
  • 7Goldstein JA, Grines C, Fischell T, et al. Coronary embo- lization following balloon dilation of lipid-core plaques [J]. JACC Cardiovasc Imaging, 2009, 2(12) : 1 420-424.
  • 8Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-re- flowin humans [J]. J Am Coil Cardiol, 2009, 54 (4) : 281-292.
  • 9Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervetion for acute myocardiol infarction on six-month mortality [J]. Am J Cardiol, 2007, 99(4) : 442-445.
  • 10Steinhubl SR, Talley JD, Braden GA, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary in- tervention: results of the GOLD (AU-Assessing Uhegra) muhicenter study [J]. Circulation, 2001, 103 (21) : 2 572-578.

引证文献16

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部